The Orphan GPR50 Receptor Regulates the Aggressiveness of Breast Cancer Stem-like Cells via Targeting the NF-kB Signaling Pathway

The expression of GPR50 in CSLC and several breast cancer cell lines was assessed by RT-PCR and online platform (UALCAN, GEPIA, and R2 gene analysis). The role of GPR50 in driving CSLC, sphere formation, cell proliferation, and migration was performed using shGPR50 gene knockdown, and the role of GPR50-regulated signaling pathways was examined by Western blotting and Luciferase Assay. Herein, we confirmed that the expression of G protein-coupled receptor 50 (GPR50) in cancer stem-like cells (CSLC) is higher than that in other cancer cells. We examined that the knockdown of GPR50 in CSLC led to decreased cancer properties, such as sphere formation, cell proliferation, migration, and stemness. GPR50 silencing downregulates NF-kB signaling, which is involved in sphere formation and aggressiveness of CSLC. In addition, we demonstrated that GPR50 also regulates ADAM-17 activity by activating NOTCH signaling pathways through the AKT/SP1 axis in CSLC. Overall, we demonstrated a novel GPR50-mediated regulation of the NF-kappa B-Notch signaling pathway, which can provide insights into CSLC progression and prognosis, and NF-kappa B-NOTCH-based CSLC treatment strategies.

Automated summary

In this study, the expression of GPR50 in CSLC and breast cancer cell lines was evaluated, and its role in CSLC progression was investigated. Knockdown of GPR50 in CSLC resulted in decreased cancer properties and stemness. GPR50 was found to regulate NF-kB and NOTCH signaling pathways, as well as ADAM-17 activity, in CSLC. Overall, this study provided novel insights into GPR50-mediated regulation of the NF-kappa B-Notch signaling pathway in CSLC and its implications for treatment strategies.